Abstract submission opens on 1 March 2014. ; Early bird registration deadline on 29 January, 2015

Important Dates

  • Abstract submission extended
    Closed
  • Abstract Notification Date
    08 Feb 2015
  • Early bird registration deadline
    29 Jan 2015
  • Event Dates
    29 April to 2 May 2015
000
00
00

Sponsors & Exhibitors

For sponsorship and exhibition sales inquiries, please contact

Mr Rakesh Chhetri
Associate Director- Conference Sales
Rakesh.Chhetri@mci-group.com
Mr Mohammed Imran
Delegate Sales Executive
Mohammed.Imran@mci-group.com  

Main Sponsor

Platinum Sponsors

About Bayer Health Care

The Bayer Group is a global enterprise with core competencies in the fields of health care, agriculture and high-tech polymer materials. As an innovation company, it sets trends in research-intensive areas. Bayer's products and services are designed to benefit people and improve the quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer HealthCare, a subgroup of Bayer AG with annual sales of ε18.9 billion (2013), is one of the world's leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Medical Care and Pharmaceuticals divisions. Bayer HealthCare's aim is to discover, develop, manufacture and market products that will improve human and animal health worldwide. Bayer HealthCare has a global workforce of 56,000 employees (Dec 31, 2013) and is represented in more than 100 countries.

About Bayer HealthCare Pharmaceuticals

Science for a better life - Health Through Medical Progress

Bayer HealthCare is among the world's foremost innovators in the field of pharmaceutical and medical products. This subgroup researches, develops, manufactures and markets products to improve thehealth of people and animals.

Bayer HealthCare Pharmaceuticals is the pharmaceutical division of Bayer HealthCare AG. We market our products in more than 100 countries, and in 2013 generated sales of ε11,188 million. 38,000 members of staff currently work for Bayer HealthCare Pharmaceuticals worldwide - 7,800 in research and development alone.

We aim to improve people's quality of life with our products. To achieve this, we concentrate on the research and development of innovative drugs and novel therapeutic approaches. At the same time, we are constantly improving established products. In this context, Bayer HealthCare Pharmaceuticals uses the experience it has gained from over a century in the business.

We concentrate on the following major therapeutic groups in which we make fundamental contributions to medical progress:

More information at www.bayer.com.

Our online press service is just a click away : www.press.healthcare.bayer.com
Follow us on Facebook : http://www.facebook.com/healthcare.bayer

  • Cardiovascular and blood diseases
  • Oncological diseases
  • Ophthalmology
  • Women's healthcare

Our Mission

To discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

BMS Our Commitment

To our patients and customers, employees, global communities, shareholders, environment and other stakeholders, we promise to act on our belief that the priceless ingredient of every product is the integrity of its maker. We operate with effective governance and high standards of ethical behavior. We seek transparency and dialogue with our stakeholders to improve our understanding of their needs. We take our commitment to economic, social and environmental sustainability seriously, and extend this expectation to our partners and suppliers.

To our patients and customers

We commit to scientific excellence and investment in biopharmaceutical research and development to provide innovative, high-quality medicines that address the unmet medical needs of patients with serious diseases. We apply scientific rigor to produce clinical and economic benefit through medicines that improve patients' lives. We strive to make information about our commercialized medicines widely and readily available.

Gold Sponsors

Silver Sponsor

AstraZeneca is one of the world's leading pharmaceutical companies engaged la the research development. manufacture and marketing of prescription pharmaceutical and the supply of healthcare services. It provides effective m rnedicines to fight disease in important areas of medical need: Cardiovascular. Gastrointestinal, Respiratory, Central Nervous System, Cancer, Pain Control and infection.

Head quartered in London it is one of the top five pharmaceutical companies in the world.

Support Sponsor

CCL Group is a rapidly growing group of companies with an extensively elaborate international set up. Our rich business portfolio includes Pharmaceuticals, Consumer Healthcare and Personal Care products.

CCL Pharmaceuticals was founded in 1965. Bearing the motto "Extending Human Life", the Company has constantly been working to amend healthcare and improve quality of life; today and tomorrow. Through our dedication and development expertise, we have evolved an enviable number of products which offer substantial health solutions. Our product portfolio is rich, covering major therapeutic areas.

To surmount the challenges ahead, we are pursuing a broad spectrum approach to the contests faced by the healthcare system and hence consistently exploring new avenues to effectuate humanity.

We sure are making a difference.

About MSD in the United Arab Emirates:

MSD has had presence in the UAE since the 1970's, and currently has one office in Dubai and one in Abu Dhabi. The total number of employees is approximately 83. MSD invests in partnerships and collaboration with local manufacturers and healthcare companies. MSD considers UAE as a priority country and continues to make all efforts to rapidly introduce innovative medicines to patients in UAE with a focus on unmet needs of patients, i.e. diabetes, cardiovascular, and several pioneering, novel vaccines. MSD in the UAE is committed to excellence in science, and has been focusing on clinical research activities in the region.

MSD works closely with customers to understand their needs and help them achieve their goals of patient care. MSD partners with health care authorities in the UAE on various programs, including an internet-based continuous medical education for health care professionals. With the approval of UAE Ministry of Health, MSD also developed patient education materials in English and Arabic, which is distributed to all clinics and health centers.

Exhibitors

  • Actelion
  • Al Mazroui Medicals
  • Algorithm
  • Alphamed/Boston
  • Candian Cardiac Center
  • City Pharmacy
  • Masimo
  • Menarini
  • Philips
  • Randox
  • Servier
  • Takeda

Important Dates

  • Abstract submission extended
    Closed
  • Abstract Notification Date
    08 Feb 2015
  • Early bird registration deadline
    29 Jan 2015
  • Event Dates
    29 April to 2 May 2015
000
00
00

Page Being Updated

Important Dates

  • Abstract submission extended
    Closed
  • Abstract Notification Date
    08 Feb 2015
  • Early bird registration deadline
    29 Jan 2015
  • Event Dates
    29 April to 2 May 2015
000
00
00

Page Being Updated

Important Dates

  • Abstract submission extended
    Closed
  • Abstract Notification Date
    08 Feb 2015
  • Early bird registration deadline
    29 Jan 2015
  • Event Dates
    29 April to 2 May 2015
000
00
00